FAQ

Maximum clot firmness

 

Topic mentions per year

Topic mentions per year

2010-2018
0520102018

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Differences in clotting parameters between species for preclinical large animal studies of cardiovascular devices
Several species of domestic animals are used in preclinical studies evaluating the safety and feasibility of medical devices… (More)
  • table 1
  • figure 1
  • figure 2
Is this relevant?
2016
2016
Decreased maximum clot firmness in rotational thromboelastometry (ROTEM®) is associated with bleeding during extracorporeal mechanical circulatory support.
BACKGROUND We aimed to characterize the coagulation disturbances which may increase the risk of bleeding, thrombosis or death… (More)
Is this relevant?
2014
2014
The effectiveness of different functional fibrinogen polymerization assays in eliminating platelet contribution to clot strength in thromboelastometry.
BACKGROUND Viscoelastic tests such as functional fibrinogen polymerization assays (FFPAs) in thrombelastography (TEG®) or… (More)
  • table 1
  • figure 1
  • figure 2
  • table 2
  • table 3
Is this relevant?
2013
2013
Impact of changes in haematocrit level and platelet count on thromboelastometry parameters.
INTRODUCTION To what extent haematocrit levels (Hct) and platelet counts (PLT) influence the measurement of parameters of… (More)
  • table 1
  • table 2
  • table 4
  • table 3
  • table 5
Is this relevant?
2012
2012
Hyperfibrinolysis in out of hospital cardiac arrest is associated with markers of hypoperfusion.
AIM OF THE STUDY This study investigated the incidence of hyperfibrinolysis upon emergency department (ED) admission in patients… (More)
  • table 1
  • figure 2
Is this relevant?
2011
2011
Comparison of hypertonic saline and mannitol on whole blood coagulation in vitro assessed by thromboelastometry.
BACKGROUND Hypertonic saline (HS) is an alternative to mannitol for decreasing intracranial pressure in traumatic brain injury… (More)
  • figure 1
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
2010
2010
In vitro factor XIII supplementation increases clot firmness in Rotation Thromboelastometry (ROTEM).
Factor XIII (F XIII) is an essential parameter for final clot stability. The purpose of this study was to determine the impact of… (More)
  • table 2
  • table 3
  • table 4
  • figure 1
  • figure 2
Is this relevant?
2010
2010
In vitro factor XIII supplementation increases clot firmness in Rotation
Factor XIII (F XIII) is an essential parameter for final clot stability. The purpose of this study was to determine the impact of… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • figure 1
Is this relevant?
2010
2010
Maize- or potato-derived hydroxyethyl starches: is there any thromboelastometric difference?
BACKGROUND Hydroxyethyl starches (HES) could differ with regard to the origin, and the influence on the coagulation of the raw… (More)
  • figure 1
  • figure 3
  • figure 2
  • figure 4
  • figure 5
Is this relevant?
2010
2010
Whole blood coagulation and platelet activation in the athlete: A comparison of marathon, triathlon and long distance cycling
INTRODUCTION Serious thrombembolic events occur in otherwise healthy marathon athletes during competition. We tested the… (More)
  • table 1
  • table 2
  • figure 1
  • figure 2
Is this relevant?